Study finds no difference in COVID anxiety between biologic and conventional drug users
NCT ID NCT07436494
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at anxiety about COVID-19 in 200 adults with rheumatic diseases who were already taking either biologic or conventional disease-modifying drugs. Researchers called participants and asked them to fill out a questionnaire about their coronavirus-related anxiety. The goal was to see if one group felt more anxious than the other. No new treatment was tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bursa City Hospital
Bursa, Türkiye, 16600, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a VR headset calm nerves before surgery?
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Nature as therapy? a new trial tests outdoor outings for anxious kids